During the past decade, Saint Louis University - Center for Vaccine Development conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 14 clinical trials were completed, i.e. on average, 60.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 11 clinical trials were completed. i.e. 110% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Louis University - Center for Vaccine Development" #1 collaborator was "Gritstone bio, Inc." with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Saint Louis University - Center for Vaccine Development" are "Influenza" (17 trials), "Avian Influenza" (6 trials), "COVID-19" (6 trials), "Influenza Immunisation" (5 trials) and "Tuberculosis" (4 trials). Many other conditions were trialed in "Saint Louis University - Center for Vaccine Development" in a lesser frequency.

Most popular intervention types in "Saint Louis University - Center for Vaccine Development" are "Biological" (39 trials), "Drug" (24 trials) and "Other" (17 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "AS03" (6 trials), "Phosphate Buffered Saline (PBS) diluent" (4 trials), "Remdesivir" (4 trials) and "A/H7N9" (3 trials). Other intervention names were less common.

The vast majority of trials in "Saint Louis University - Center for Vaccine Development" are 42 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Saint Louis University - Center for Vaccine Development". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Saint Louis University - Center for Vaccine Development, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Saint Louis University - Center for Vaccine Development, 23 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".